Evaluation of short-term changes in serum creatinine level as a meaningful end point in randomized clinical trials

Journal of the American Society of Nephrology

Volumn 27, Issue 8, 2016, Pages 2529-2542

  Coca, Steven G ^a   Zabetian, Azadeh ^b   Ferket, Bart S ^a   Zhou, Jing ^a   Testani, Jeffrey M ^b   Garg, Amit X ^c   Parikh, Chirag R ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; CHLORIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RENIN INHIBITOR; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL OUTCOME; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART SURGERY; HUMAN; MEAN ARTERIAL PRESSURE; META ANALYSIS; MORTALITY RATE; MULTICENTER STUDY (TOPIC); OFF PUMP SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SELECTION BIAS; SENSITIVITY ANALYSIS; SEPTIC SHOCK; SYSTEMATIC REVIEW; ACUTE KIDNEY INJURY; BIOASSAY; BLOOD; PROCEDURES; RISK ASSESSMENT; TIME FACTOR;

ACUTE KIDNEY INJURY; CREATININE; ENDPOINT DETERMINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TIME FACTORS;

EID: 84991235853     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015060642     Document Type: Article

References (45)

1. Coca SG, Singanamala S, Parikh CR: Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis. Kidney Int 81: 442-448, 2012
2. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR: Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 53: 961-973, 2009
3. Chawla LS, Eggers PW, Star RA, Kimmel PL: Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371: 58-66, 2014
4. Basile DP, Donohoe D, Roethe K, Osborn JL: Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887-F899, 2001
5. Basile DP, Donohoe DL, Roethe K, Mattson DL: Chronic renal hypoxia after acute ischemic injury: Effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 284: F338-F348, 2003
6. Pechman KR, Basile DP, Lund H, Mattson DL: Immune suppression blocks sodium-sensitive hypertension following recovery fromischemic acute renal failure. Am J Physiol Regul Integr Comp Physiol 294: R1234-R1239, 2008
7. Pechman KR, De Miguel C, LundH, Leonard EC, Basile DP,Mattson DL: Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodiumsensitive hypertension. Am J Physiol Regul Integr Comp Physiol 297: R1358-R1363, 2009
8. Spurgeon-Pechman KR, Donohoe DL, Mattson DL, Lund H, James L, Basile DP: Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium. Am J Physiol Renal Physiol 293: F269-F278, 2007
9. Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, KellumJA, Chinchilli VM, Liu KD, Cheung AK,Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT,Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA: Design of clinical trials in acute kidney injury: Report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol 7: 844-850, 2012
10. Fried LF, Emanuele N, Zhang JH, BrophyM, Conner TA, DuckworthW, Leehey DJ, McCullough PA, O'Connor T, Palevsky PM, Reilly RF, Seliger SL,Warren SR, Watnick S, Peduzzi P, Guarino P; VA NEPHROND Investigators: Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 369: 1892-1903, 2013
11. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF,O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM; TOPCAT Investigators: Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370: 1383-1392, 2014
12. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, NicolaidesM, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators: Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367: 2204-2213, 2012
13. Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP; ASTRONAUT Investigators and Coordinators: Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial. JAMA 309: 1125-1135, 2013
14. Maggioni AP, Greene SJ, Fonarow GC, Böhm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M; ASTRONAUT Investigators and Coordinators: Effect of aliskiren on post-discharge outcomes among diabetic and nondiabetic patients hospitalized for heart failure: Insights from the ASTRONAUT trial. Eur Heart J 34: 3117-3127, 2013
15. Cohn JN, Tognoni G; Valsartan Heart Failure Trial Investigators: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345: 1667-1675, 2001
16. Lesogor A, Cohn JN, Latini R, Tognoni G, Krum H, Massie B, Zalewski A, Kandra A, Hua TA, Gimpelewicz C: Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensinaldosterone system blockade in patients with heart failure: Insights from the Val-HeFT study. Eur J Heart Fail 15: 1236-1244, 2013
17. Rossignol P, Dobre D, McMurray JJ, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Messig M, Vincent J, Girerd N, Bakris G, Pitt B, Zannad F: Incidence, determinants, and prognostic significance of hyperkalemia andworsening renal function in patientswith heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Circ Heart Fail 7: 51-58, 2014
18. Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group: Eplerenone in patients with systolic heart failure and mild symptoms. NEngl JMed 364: 11-21, 2011
19. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C; ONTARGET Investigators: Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358: 1547-1559, 2008
20. Mann JF, Schmieder RE, McQueenM, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K,Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S; ONTARGET investigators: Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (theONTARGET study): A multicentre, randomised, double-blind, controlled trial. Lancet 372: 547-553, 2008
21. Sezai A, Hata M, Niino T, Yoshitake I, Unosawa S, Wakui S, Fujita K, Takayama T, Kasamaki Y, Hirayama A, Minami K: Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting: The NU-HIT (Nihon University working group study of low-dose Human ANP Infusion Therapy during cardiac surgery) for left ventricular dysfunction. J Am Coll Cardiol 55: 1844-1851, 2010
22. Sezai A, Hata M, Niino T, Yoshitake I, Unosawa S, Wakui S, Kimura H, Shiono M, Takayama T, Hirayama A: Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: The NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD. J Am Coll Cardiol 58: 897-903, 2011
23. Garg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, WalshM, Novick R, Cook RJ, Jain AR, Pan X, NoiseuxN, Vik K, Stolf NA, Ritchie A, Favaloro RR, Parvathaneni S, Whitlock RP,Ou Y, LawrenceM, Lamy A; CORONARY Investigators: Kidney function after off-pump or on-pump coronary artery bypass graft surgery: A randomized clinical trial. JAMA 311: 2191-2198, 2014
24. Miner SE, Dzavik V,Nguyen-Ho P, Richardson R, Mitchell J, Atchison D, Seidelin P, Daly P, Ross J, McLaughlin PR, Ing D, Lewycky P, Barolet A, Schwartz L: N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up. Am Heart J 148: 690-695, 2004
25. Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, Mira JP, Dequin PF, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R,Gonzalez F, GuittonC, Tamion F, Tonnelier JM,Guezennec P, Van Der Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard JD, Hervé F, du Cheyron D, Guerin C, Mercat A, Teboul JL, Radermacher P; SEPSISPAM Investigators: High versus low bloodpressure target in patients with septic shock. N Engl JMed 370: 1583-1593, 2014
26. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M: Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308: 1566-1572, 2012
27. Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AY, Jorgensen M, Dua A, Short L, Kane K: Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: The POSEIDON randomised controlled trial. Lancet 383: 1814-1823, 2014
28. Ishani A, Nelson D, Clothier B, Schult T, Nugent S, Greer N, Slinin Y, Ensrud KE: The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 171: 226-233, 2011
29. Newsome BB, Warnock DG, McClellan WM, Herzog CA, Kiefe CI, Eggers PW, Allison JJ: Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 168: 609-616, 2008
30. Lo LJ,Go AS, ChertowGM,McCulloch CE, Fan D,Ordoñez JD, Hsu CY: Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76: 893-899, 2009
31. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, Collins AJ: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20: 223-228, 2009
32. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG; University of Toronto Acute Kidney Injury ResearchGroup: Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302: 1179-1185, 2009
33. Hsu CY: Yes, AKI truly leads to CKD. J Am Soc Nephrol 23: 967-969, 2012
34. Coca SG, Garg AX, Swaminathan M, Garwood S, Hong K, Thiessen-Philbrook H, Passik C, Koyner JL, Parikh CR; TRIBE-AKI Consortium: Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant 28: 2787-2799, 2013
35. Shah M, Jain AK, Brunelli SM, Coca SG, Devereaux PJ, James MT, Luo J, Molnar AO,MrkobradaM, Pannu N, Parikh CR, Paterson M, Shariff S, Wald R, Walsh M, Whitlock R, Wijeysundera DN, Garg AX: Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol 15: 53, 2014
36. Cairns JA, Yusuf S, Cook RJ, Cox J, Dagenais GR, Devereaux PJ, McAlister FA, McCready T; CANNeCTIN: Canadian Network and Centre for Trials Internationally (CANNeCTIN): A national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus. Can J Cardiol 26: 353-358, 2010
37. HaaseM, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN,Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C,Martensson J,Martling CR, Venge P, Siew E,Ware LB, Ikizler TA, Mertens PR: The outcome of neutrophil gelatinaseassociated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J Am Coll Cardiol 57: 1752-1761, 2011
38. Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, Elger A,Maarouf O, Sola-Del Valle DA, O'RourkeM, Sherman E, Lee P, Geara A, Imus P, Guddati A, Polland A, Rahman W, Elitok S, Malik N, Giglio J, El-Sayegh S, Devarajan P, Hebbar S, Saggi SJ, Hahn B, Kettritz R, Luft FC, Barasch J: Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: Amulticenter prospective cohort study. JAmColl Cardiol 59: 246-255, 2012
39. Coca SG, Garg AX, Thiessen-Philbrook H, Koyner JL, Patel UD, Krumholz HM, Shlipak MG, Parikh CR; TRIBE-AKI Consortium: Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J AmSoc Nephrol 25: 1063-1071, 2014
40. Molnar AO, Parikh CR, Coca SG, Thiessen-Philbrook H, Koyner JL, Shlipak MG, Lee Myers M, Garg AX; TRIBE-AKI Consortium: Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg 97: 2081-2087, 2014
41. Coca SG, King JT Jr., Rosenthal RA, PerkalMF, Parikh CR: The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int 78: 926-933, 2010
42. Brown JR, Kramer RS, Coca SG, Parikh CR: Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg 90: 1142-1148, 2010
43. Pickering JW, Frampton CM, Endre ZH: Evaluation of trial outcomes in acute kidney injury by creatinine modeling. Clin J Am Soc Nephrol 4: 1705-1715, 2009
44. Hildebrand AM, Iansavichus AV, Haynes RB, Wilczynski NL, Mehta RL, Parikh CR, Garg AX: High-performance information search filters for acute kidney injury content in PubMed, Ovid Medline and Embase. Nephrol Dial Transplant 29: 823-832, 2014
45. Riley RD, Thompson JR, Abrams KR: An alternative model for bivariate random-effects meta-analysis when the within-study correlations are unknown. Biostatistics 9: 172-186, 2008